Social Care News and Research

RSS

One dose of Pfizer vaccine generates strong immune response against COVID-19

A new study led by the Universities of Sheffield and Oxford with support from the UK Coronavirus Immunology Consortium (UK-CIC) has found that 99 per cent of people generate a robust immune response against Covid-19 after just one dose of the Pfizer vaccine.

26 Mar 2021

SARS-CoV-2 vaccination should be carefully targeted towards certain groups, say researchers

Researchers in the UK have provided important insights into the impact that vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – may have on infection rates, disease prevalence and immune escape by the virus.

18 Mar 2021

Personal protective equipment distributed during COVID-19 has biggest environmental impact

According to a new study published in the Journal of the Royal Society of Medicine, the carbon footprint of personal protective equipment (PPE) provided to health and social care staff in England during the first six months of the COVID-19 pandemic was equivalent to flying from London to New York 244 times every day.

18 Mar 2021

Study: Slow walkers have higher risk of contracting severe COVID-19

SLOW walkers are almost four times more likely to die from COVID-19, and have over twice the risk of contracting a severe version of the virus, according to a team of researchers from the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre led by Professor Tom Yates at the University of Leicester.

16 Mar 2021

Research reveals public preferences towards paying for social care in old age

Nearly 60 per cent of the public in England thinks that the cost of social care in later life should be shared by the state and the individual, even for people with substantial resources, according to joint research by the London School of Economics and Political Science and the London School of Hygiene & Tropical Medicine .

15 Mar 2021

Cognitive behavioral therapy can reduce dental anxiety in children

A pioneering study led by the University of Sheffield and Sheffield Teaching Hospitals will investigate whether Cognitive Behavioral Therapy (CBT) could help reduce the worryingly high number of children who are afraid of the dentist.

15 Mar 2021

Two simple steps that could be taken to tackle the ‘obesity time bomb’

The urgency of tackling the obesity time bomb has been brought to the fore by evidence of the link to an increased risk from COVID-19, says the UK Government's Department of Health and Social Care.

13 Mar 2021

Research reveals increased risk of COVID-19 among women with PCOS

Women with polycystic ovary syndrome (PCOS) are at a significantly increased risk of contracting COVID-19 than women without the condition, new research led by the University of Birmingham has revealed.

9 Mar 2021

New research project aims to treat patients with secondary brain damage

The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.

9 Mar 2021

Rare Disease Day: Illumina shines a spotlight on people living with rare diseases

With a mission of empowering the rare disease community, Illumina has today partnered with medical researchers and families to highlight the importance of genomic sequencing and to shine the spotlight on the 300 million people worldwide living with a rare disease.

8 Mar 2021

Study: Major changes in bereavement care occurred during COVID-19 pandemic

Major changes in bereavement care have occurred during the COVID-19 pandemic, amid a flood of demand for help from bereaved people, according to new research from the University of Cambridge.

1 Mar 2021

Salt reduction program will lead to health benefits, cost savings by 2050

England's salt reduction programme will have led to nearly 200,000 fewer adults developing heart disease and £1.64 billion of healthcare cost savings by 2050, according to research by Queen Mary University of London.

22 Feb 2021

Study forecasts post-COVID-19 hospital activity among children and young people in England

An intriguing new study by researchers in the UK explores attendance and admissions in various hospital areas, including inpatient – outpatient and emergency department (ED) – by children and up to 24 years olds (children and young people, CYP).

18 Feb 2021

LifeArc supports the GenOMICC COVID-19 Study

Medical research charity, LifeArc, announces today that it is providing £5 million funding to support the work of the GenOMICC COVID-19 Study, led by the GenOMICC consortium in partnership with Genomics England.

15 Feb 2021

HIV self-testing increases testing uptake and frequency in trans people

HIV self-testing could reduce the time between HIV infection and HIV diagnosis amongst trans people when compared to standard testing services, suggests new research in EClinicalMedicine.

11 Feb 2021

Study identifies gap between theory and reality of dispensing medication

A study published in the journal Applied Ergonomics compared the standardized processes set out for community pharmacists to follow when dispending medication to what happens in reality. A gap was revealed and researchers also looked at the reasons for this.

4 Feb 2021

Studies show slowing of UK life expectancy after financial crisis

Increases in life expectancy in the UK and elsewhere had slowed even before 2016 - and COVID-19 is expected to further eliminate any gains, Newcastle University studies show.

1 Feb 2021

Obesity may contribute toward neural tissue vulnerability, exacerbate Alzheimer's disease

New research from the University of Sheffield has found being overweight is an additional burden on brain health and it may exacerbate Alzheimer's disease.

29 Jan 2021

New study aims to improve the support and care for people affected by 'long COVID'

A new £375,000 study led by the University of Stirling is seeking to understand the lived experiences and support needs of people suffering from the long-term effects of COVID-19.

28 Jan 2021

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

27 Jan 2021